Coave Therapeutics

Investment area

Seed Investments

Region

Europe

Date of investment

January 2025

Coave Therapeutics is a genetic medicine company pioneering the development of innovative solutions to enhance the precision, safety, efficacy and manufacturability of genetic medicines.